PANOME BIO INC

SAINT LOUIS, MO · Founded 2022 · CIK 0001966691 · Biotech · Private

Multi-omics analysis platform providing metabolomics, proteomics, and transcriptomics services

panomebio.com →
Grants
$882K
1 award
Sector median: 1
Raised
$12M
2 Form D · Nov 2024
22 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,973,835
Private capital raisedForm D · SEC$6,000,000
Federal grantDepartment of Health and Human Services · Phase II · Biomarker discovery in colon cancer through next-generation metabolomics$881,647
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2484Incannex Healthcare Inc.—$12M
2485Genialis, Inc.—$12M
2486Borealis Biosciences——
2487PANOME BIO INC—$12M
2488ANAVEX LIFE SCIENCES CORP.—$11M
2489APPLIED GENETIC TECHNOLOGIES CORPORATION—$9.3M
24903+2 PHARMA, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Rob CaponeDirector
  • Tom CohenExecutive Officer
  • Alexander HerzickDirector
  • Deval LashkariDirector
  • David SmollerDirector
  • Edward WeinsteinDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.